@article{AMJ3765,
author = {Farhan Gohar and Dhiraj Tripathi},
title = {Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: an unmet need finally met?},
journal = {AME Medical Journal},
volume = {2},
number = {4},
year = {2017},
keywords = {},
abstract = {Non-selective beta blocker (NSBB) therapy remains the front runner in the treatment of portal hypertension. Over the years, our understanding of their mechanisms of action, both haemodynamic and non-haemodynamic, has evolved. Variceal bleeding, an inevitable consequence of portal hypertension, accounts for 10% of all admissions with gastrointestinal bleeding, and has an inpatient mortality of 15% and 1 year mortality of up to 40% (1). Reducing the risk of the development of varices (pre-primary prophylaxis) and the first variceal bleed (primary prevention) are therefore important clinical goals.},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/3765}
}